SN
Synektik Spólka Akcyjna
SNT.WA · WSE
338.80 zł -0.82% (-2.80 zł)
1M +0.89%
Market Cap 2.91B zł
P/E Ratio 6.97x
Div. Yield 3.15%
ROE 195.48%
Bulios Fair Price
226.54 zł
33.1% downside
Current Price
338.8 zł
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SNT.WA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
67 /100
Cheap P/FCF 18.98x
P/S 3.12x
P/B 13.58x
Growth
100 /100
Growing Rev. growth 59.83%
Book val. growth 36.37%
EPS growth 111.97%
Profitability
91 /100
Strong Net margin 44.75%
Op. margin 24.16%
FCF margin 16.43%
Quality
100 /100
Excellent ROE 195.48%
ROA 73.76%
Asset turnover 1.65x
Debt
96 /100
Low Current ratio 1.46x
Int. coverage 35.73x
Net debt/EBITDA -0.14x
Stability
15 /100
Unstable Rev. volatility 84.18%
EPS volatility 201.27%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SNT.WA
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Cezary Dariusz Kozanecki
Employees
239
Headquarters
Warsaw
Upcoming events
02 DEC
Earnings
Upcoming earnings report